X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
index medicus (41) 41
stroke (36) 36
female (35) 35
male (35) 35
middle aged (33) 33
aged (32) 32
risk factors (25) 25
clinical neurology (20) 20
peripheral vascular disease (17) 17
cardiac & cardiovascular systems (16) 16
prevention (15) 15
stroke - prevention & control (15) 15
treatment outcome (15) 15
adult (14) 14
atrial fibrillation (14) 14
risk (13) 13
aged, 80 and over (12) 12
stroke - etiology (12) 12
abridged index medicus (11) 11
mortality (11) 11
prospective studies (10) 10
stroke - drug therapy (10) 10
time factors (10) 10
aspirin (9) 9
cardiovascular disease (9) 9
cholesterol (9) 9
management (9) 9
medicine, general & internal (9) 9
therapy (9) 9
neurology (8) 8
patients (8) 8
risk assessment (8) 8
statins (8) 8
anticoagulants (7) 7
atherosclerosis (7) 7
care and treatment (7) 7
drug therapy (7) 7
heart attacks (7) 7
ischemia (7) 7
medical colleges (7) 7
original paper (7) 7
stroke - diagnosis (7) 7
stroke - mortality (7) 7
transient ischemic attack (7) 7
acute ischemic-stroke (6) 6
anticoagulants - therapeutic use (6) 6
cardiovascular (6) 6
clinical trials (6) 6
clopidogrel (6) 6
double-blind method (6) 6
fibrinolytic agents - adverse effects (6) 6
follow-up studies (6) 6
guidelines (6) 6
hemorrhage (6) 6
outcomes (6) 6
platelet aggregation inhibitors - therapeutic use (6) 6
severity of illness index (6) 6
studies (6) 6
thrombolysis (6) 6
warfarin (6) 6
analysis (5) 5
atrial fibrillation - drug therapy (5) 5
blood pressure (5) 5
cardiology and cardiovascular medicine (5) 5
cerebral infarction (5) 5
controlled-trial (5) 5
fibrinolytic agents - administration & dosage (5) 5
ischemic attack, transient - complications (5) 5
ischemic attack, transient - drug therapy (5) 5
lipids (5) 5
myocardial infarction (5) 5
patient outcomes (5) 5
prevalence (5) 5
prognosis (5) 5
randomized controlled trials as topic (5) 5
registries (5) 5
stroke - complications (5) 5
stroke prevention (5) 5
acute coronary syndromes (4) 4
anticholesteremic agents - therapeutic use (4) 4
anticoagulation (4) 4
aspirin - therapeutic use (4) 4
atrial fibrillation - complications (4) 4
atrial-fibrillation (4) 4
bleeding (4) 4
cardiology (4) 4
cardiovascular agents (4) 4
cardiovascular diseases (4) 4
cardiovascular events (4) 4
carotid stenosis - complications (4) 4
cholesterol, ldl - blood (4) 4
coronary-heart-disease (4) 4
diabetes (4) 4
disease (4) 4
early risk (4) 4
embolism (4) 4
fibrinolytic agents - therapeutic use (4) 4
health aspects (4) 4
hemorrhage - chemically induced (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Swerdlow, Daniel I, Dr and Preiss, David, Dr and Kuchenbaecker, Karoline B, MSc and Holmes, Michael V, PhD and Engmann, Jorgen E L, MSc and Shah, Tina, PhD and Sofat, Reecha, MD and Stender, Stefan, MD and Johnson, Paul C D, PhD and Scott, Robert A, PhD and Leusink, Maarten, MSc and Verweij, Niek, MD and Sharp, Stephen J, MSc and Guo, Yiran, PhD and Giambartolomei, Claudia, MSc and Chung, Christina, MSc and Peasey, Anne, PhD and Amuzu, Antoinette, MSc and Li, KaWah, MSc and Palmen, Jutta, MSc and Howard, Philip, MSc and Cooper, Jackie A, MSc and Drenos, Fotios, PhD and Li, Yun R, BSc and Lowe, Gordon, Prof and Gallacher, John, PhD and Stewart, Marlene C W, PhD and Tzoulaki, Ioanna, PhD and Buxbaum, Sarah G, PhD and van der A, Daphne L, PhD and Forouhi, Nita G, MRCP and Onland-Moret, N Charlotte, PhD and van der Schouw, Yvonne T, Prof and Schnabel, Renate B, MD and Hubacek, Jaroslav A, PhD and Kubinova, Ruzena, MD and Baceviciene, Migle, MD and Tamosiunas, Abdonas, Prof and Pajak, Andrzej, Prof and Topor-Madry, Romanvan, MD and Stepaniak, Urszula, PhD and Malyutina, Sofia, Prof and Baldassarre, Damiano, PhD and Sennblad, Bengt, PhD and Tremoli, Elena, Prof and de Faire, Ulf, Prof and Veglia, Fabrizio, PhD and Ford, Ian, Prof and Jukema, J Wouter, Prof and Westendorp, Rudi G J, Prof and de Borst, Gert Jan, MD and de Jong, Pim A, MD and Algra, Ale, Prof and Spiering, Wilko, MD and der Zee, Anke H Maitland-van, PhD and Klungel, Olaf H, PharmD and de Boer, Anthonius, Prof and Doevendans, Pieter A, Prof and Eaton, Charles B, Prof and Robinson, Jennifer G, Prof and Duggan, David, PhD and Kjekshus, John, Prof and Downs, John R, MD and Gotto, Antonio M, MD and Keech, Anthony C, MD and Marchioli, Roberto, MD and Tognoni, Gianni, MD and Sever, Peter S, Prof and Poulter, Neil R, Prof and Waters, David D, MD and Pedersen, Terje R, MD and Amarenco, Pierre, MD and Nakamura, Haruo, MD and McMurray, John J V, Prof and Lewsey, James D, PhD and Chasman, Daniel I, PhD and Ridker, Paul M, MD and Maggioni, Aldo P, Prof and Tavazzi, Luigi, Prof and Ray, Kausik K, Prof and Seshasai, Sreenivasa Rao Kondapally, MD and Manson, JoAnn E, Prof and Price, Jackie F, MD and Whincup, Peter H, Prof and Morris, Richard W, Prof and Lawlor, Debbie A, Prof and Smith, George Davey, Prof and Ben-Shlomo, Yoav, Prof and Schreiner, Pamela J, Prof and Fornage, Myriam, Prof and Siscovick, David S, Prof and Cushman, Mary, MD and Kumari, Meena, PhD and Wareham, Nick J, Prof and Verschuren, W M Monique, PhD and Redline, Susan, Prof and Patel, Sanjay R, MD and Whittaker, John C, Prof and Hamsten, Anders, Prof and Delaney, Joseph A, PhD and ... and MAGIC Consortium and InterAct Consortium and DIAGRAM Consortium
The Lancet, ISSN 0140-6736, 01/2015, Volume 385, Issue 9965, pp. 351 - 361
Journal Article
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2009, Volume 8, Issue 9, pp. 802 - 809
Summary Background The efficacy of intravenous (IV) alteplase is restricted by the speed of recanalisation and the site of the occlusion. The aim of this study... 
Neurology | CONTROLLED-TRIAL | INTRAARTERIAL | INTERVENTIONAL MANAGEMENT | THERAPY | TISSUE-PLASMINOGEN-ACTIVATOR | CLINICAL RECOVERY | PREDICTORS | ACUTE ISCHEMIC-STROKE | THROMBOLYSIS | INFUSION | CLINICAL NEUROLOGY | Intracranial Thrombosis - complications | Postoperative Complications - etiology | Prospective Studies | Injections, Intra-Arterial - statistics & numerical data | Recovery of Function - drug effects | Humans | Middle Aged | Clinical Protocols | Male | Stroke - physiopathology | Tissue Plasminogen Activator - adverse effects | Cerebral Arteries - drug effects | Fibrinolytic Agents - adverse effects | Thrombolytic Therapy - methods | Aged, 80 and over | Recovery of Function - physiology | Female | Intracranial Thrombosis - drug therapy | Drug Administration Routes | Intracranial Thrombosis - physiopathology | Cerebral Arteries - diagnostic imaging | Injections, Intra-Arterial - adverse effects | Thrombolytic Therapy - statistics & numerical data | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Stroke - drug therapy | Radiography | Stroke - etiology | Cerebral Arteries - pathology | Aged | Fibrinolytic Agents - administration & dosage | Injections, Intravenous - statistics & numerical data | Thrombolytic Therapy - adverse effects | Cohort Studies | Stroke (Disease) | Medicine, Experimental | Medical research | Care and treatment | Comparative analysis | Tissue plasminogen activator | Index Medicus
Journal Article
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 113, Issue 8, pp. 1378 - 1382
Journal Article
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2014, Volume 23, Issue 4, pp. 778 - 784
Journal Article